Navigation Links
DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
Date:10/28/2009

WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that global sales volumes of the Levulan® Kerastick®, an integral part of the Levulan® Photodynamic Therapy (PDT) technology platform, surpassed one million units.

"The achievement of this milestone signifies that dermatologists in the U.S. and abroad continue to embrace Levulan PDT for Grade 1 and 2 actinic keratoses (AKs) of the face and scalp and the beneficial outcomes it offers their patients," said Bob Doman, DUSA's President and Chief Executive Officer.

"We believe that Levulan PDT is one of the fastest growing office based procedures in dermatology today, having achieved a 39% compounded annual growth rate in worldwide Kerastick revenues over the past four years," continued Doman.

"PDT is an important, versatile technology that should be integrated more frequently in clinical dermatology practice," said Jill Waibel, M.D., a dermatologist in private practice at Palm Beach Esthetic Dermatology & Laser Center, West Palm Beach, Florida.

"We are excited to have reached the one million Kerastick sales milestone, and believe that significant growth potential exists for Levulan PDT in the treatment of AKs and other potential indications," Doman concluded.

DUSA continues to explore other potential indications for the utilization of Levulan PDT for the treatment of various skin conditions and has initiated a pilot study on Levulan PDT for the treatment of AKs and the prevention of new non-melanoma skin cancer in chronically immunosuppressed solid organ transplant recipients.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. ® is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therap
'/>"/>

SOURCE DUSA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
2. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
3. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
4. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
5. BioMarin Acquires Huxley Pharmaceuticals, Inc.
6. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
7. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
9. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
10. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
11. Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Iowa, Dec. 15 Vivakor, Inc. ... Vivakor,s divisions have reported strong performance in ... research and development with divisional spokes developing ... R&D Product Pipeline strategy is anchored to ... From idea inception, Vivakor,s R&D efforts target ...
(Date:12/15/2009)... Calif., Dec. 15 Genomic Health, Inc. (Nasdaq: ... studies on its Onco type DX® breast cancer ... to predict the likelihood of chemotherapy benefit and recurrence ... were presented at the 32nd Annual CTRC-AACR San Antonio ... in San Antonio, TX. ,, "The breadth of data ...
(Date:12/15/2009)... Mass., Dec. 15 Arlington Medical Resources ... Staphylococcus aureus (MRSA) is the most concerning ... regard to their treatment of skin and skin ... among the top factors that influences European physician ... infections. Other key factors that drive prescribing include ...
Breaking Medicine Technology:Vivakor Divisions Continue to Demonstrate Independent Growth 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection USP 15 mg mL 3B 1mL Single Dose Vials 5964 1American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection USP 15 mg mL 3B 1mL Single Dose Vials 5964 2Study 3A Lap band surgery effective for morbidly obese children 60640 1Renowned cardiovascular researcher to receive Taylor Prize 60638 1
(Date:12/15/2009)... Continuing Strike Force Operations Lead to Indictment of ... with more than $61 Million in Fraudulent Billing ... Thirty people have been charged in ... to submit more than $61 million in false ... of the Medicare Fraud Strike Force, Department of ...
(Date:12/15/2009)... call for help, experts say , , TUESDAY, Dec. 15 ... teaching children how to spot the signs of stroke ... study shows. , Emergency medical treatment within three hours ... of brain damage and lead to better recovery. , ... 515 sixth graders in Texas who were divided into ...
(Date:12/15/2009)... doctors decide benefits of imaging outweigh the risks , , ... pose a serious risk to people with heart pacemakers, ... exposed pacemakers to a simulated MRI magnetic field and ... of the pacemaker lead, where it would touch the ... MRI magnetic pulses caused certain pacemakers to deliver a ...
(Date:12/15/2009)... -- Virtual Health Technologies, Inc. (OTC Bulletin Board: ... owned operating subsidiary of VHGI) has appointed two ... to assist with bringing the Treasure Gulch and ... as possible. Additionally, the company is informing interested ... schedule a Live Investor Town Hall Meeting so ...
(Date:12/15/2009)... Aon Consulting, the global human ... AON ), today announced Lisa ... vice president with the Health & Benefits ... Practice. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ... will work under the direction of Aon ...
Breaking Medicine News(10 mins):Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 2Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 3Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 4
... April 17 Young Innovations,Inc. (Nasdaq: YDNT ) ... results with a live and on-demand web cast conference ... Time. A live audio,broadcast of the call will be ... live audio broadcast,will also be available through the Company,s ...
... long hours, night shifts or job insecurity, study says , , ... as conflicts with bosses or co-workers are more likely than ... sleep. , That,s the conclusion of a study by University ... about 2,300 U.S. adults who were followed for up to ...
... in patients , , THURSDAY, April 17 (HealthDay News) -- ... Alzheimer,s drug reinforces the notion that the compound is ... to moderate Alzheimer,s patients. , A second analysis of ... reveals that by improving the Alzheimer,s patients, ability to ...
... A childs innocence and vulnerability presents a target ... researchers are beginning to understand the communication process by ... This information could better equip parents and community members ... child sexual abuse. , Our children are our greatest ...
... Typing on a keyboard or scribbling on paper may be ... the body moves, according to new motor development research. , ... that lead to words, and we use grammar to put ... of health and kinesiology. "One of the fundamental questions in ...
... 17 The Juvenile,Products Manufacturers Association (JPMA), which ... United States, stands by the,scientific research indicating that ... scientific evaluation process of the National,Toxicology Program,s (NTP) ... Following an expert panel review last year, this ...
Other Medicine News:Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2Health News:Work Conflicts Can Do a Job on Your Sleep 2Health News:Experimental Alzheimer's Drug Shows Promise 2Health News:Experimental Alzheimer's Drug Shows Promise 3Health News:MU researchers reveal communication tactics used by sexual predators to entrap children 2Health News:New research shows slight of hand is not so slight 2Health News:Juvenile Products Manufacturers Association Supports Safety of Baby Bottles 2
The clarity and performance of glass with shatterproof safety of plastic....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... technology uses advanced spectral analysis techniques ... images and provide detailed information on ... plaques. The colorized VH images show ... dense calcium, and necrotic core. VH ...
... Medtronic is changing the way clinicians and ... Medtronic CareLink Monitor and a standard phone ... from their home or while traveling. 1 ... the ability to review device data when ...
Medicine Products: